PHC Holdings Corporation (6523.T)
JPY 953.0
(1.6%)
JPY 953.0
(1.6%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 39.08 Billion JPY | -26.67% |
| 2022 | 58.42 Billion JPY | 18.81% |
| 2021 | 56.88 Billion JPY | -35.29% |
| 2020 | 62.29 Billion JPY | 59.69% |
| 2019 | 38.26 Billion JPY | 2.94% |
| 2018 | 38.69 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 9.41 Billion JPY | -60.07% |
| 2023 Q4 | 12.02 Billion JPY | 660.11% |
| 2023 FY | - JPY | -26.67% |
| 2023 Q3 | -2.14 Billion JPY | -123.04% |
| 2023 Q2 | 9.31 Billion JPY | 6.87% |
| 2023 Q1 | 8.71 Billion JPY | 55.66% |
| 2022 Q3 | 18.36 Billion JPY | -4.79% |
| 2022 Q1 | 9.57 Billion JPY | 206.24% |
| 2022 Q4 | 5.59 Billion JPY | -69.52% |
| 2022 FY | - JPY | 18.81% |
| 2022 Q2 | 19.28 Billion JPY | 101.56% |
| 2021 FY | - JPY | -35.29% |
| 2021 Q1 | 24.09 Billion JPY | 18.68% |
| 2021 Q3 | 18.35 Billion JPY | 12.05% |
| 2021 Q2 | 16.37 Billion JPY | -32.03% |
| 2021 Q4 | -9 Billion JPY | -149.09% |
| 2020 FY | - JPY | 59.69% |
| 2020 Q2 | 15.48 Billion JPY | 145.61% |
| 2020 Q1 | 6.3 Billion JPY | 0.0% |
| 2020 Q3 | 19.49 Billion JPY | 25.94% |
| 2020 Q4 | 20.3 Billion JPY | 4.13% |
| 2019 FY | - JPY | 2.94% |
| 2018 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| DVx Inc. | 807.98 Million JPY | -4737.596% |
| Seikagaku Corporation | 2.09 Billion JPY | -1764.838% |
| Eiken Chemical Co., Ltd. | 5.7 Billion JPY | -585.136% |
| Create Medic Co., Ltd. | 1.39 Billion JPY | -2709.201% |
| Techno Medica Co., Ltd. | 1.95 Billion JPY | -1901.159% |
| Rion Co., Ltd. | 4.37 Billion JPY | -793.071% |
| Nihon Kohden Corporation | 23.44 Billion JPY | -66.718% |
| Fukuda Denshi Co., Ltd. | 36.23 Billion JPY | -7.88% |
| Japan Lifeline Co., Ltd. | 12.39 Billion JPY | -215.472% |
| Japan Medical Dynamic Marketing, INC. | 3.27 Billion JPY | -1094.112% |
| 3-D Matrix, Ltd. | 2.09 Billion JPY | -1768.403% |
| CYBERDYNE Inc. | -2 Million JPY | 1954450.0% |